BioLineRx, Ltd.

18 clinical trials · Sponsor

Record	Firm	Date
Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects (NCT05293171)	BioLineRx, Ltd.	2021-06-11
A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM) (NCT03246529)	BioLineRx, Ltd.	2018-03-23
Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML) (NCT03154827)	BioLineRx, Ltd.	2018-01-08

Every clearance here is in the API, with alerts when new ones post.